APRN-Led Simulation Speeds Time to First Shock in ICU
Nursing simulation intervention improves compliance with guidelines on time to first shock in ICU patients with ventricular fibrillation or tachycardia
Arrhythmia
Can a Mobile Health Tech Program Help Patients With Atrial Fibrillation, Multimorbidity?
Researchers investigated whether a mobile health technology program for older adults with AF and multimorbidity would help decrease AF-related adverse events.
Edoxaban Non-Inferior to Vitamin K Antagonists in Atrial Fibrillation Post-TAVR
Researchers conducted a clinical trial to assess the composite cardiorenal outcomes of finerenone therapy in patients with CKD and T2D.
Black, Hispanic Patients With Atrial Fibrillation Less Likely to Start Anticoagulants
Researchers investigated racial and ethnic disparities in anticoagulation initiation in patients dually enrolled in the Veterans Health Administration and Medicare.
Cardiac Sarcoidosis With Ventricular Arrhythmia May Lead to Worse Outcomes
Using a retrospective review, researchers analyzed outcomes of patients diagnosed with cardiac sarcoidosis by comparing MRI and PET findings vs clinical presentation.
Screening for Atrial Fibrillation Among Older Adults Safe and Beneficial
Researchers sought to determine whether screening vs no screening for atrial fibrillation could reduce morbidity and mortality.
Long-Term Performance, Safety of First Modular Cardiac Rhythm Management System
Researchers from a preclinical trial examined safety and performance of a 2-part cardiac rhythm management system, consisting of a leadless pacemaker and S-ICD.
Patients With Atrial Fibrillation, Diabetes Less Often Notice AF Symptoms
Using data on patients with existing atrial fibrillation (AF), researchers analyzed the link between diabetes with the AF phenotype and cardiac and neurologic comorbidities.
Breast Cancer Linked to Increased Risk for AF, 1-Year CV Mortality
A team of researchers sought to identify the association between atrial fibrillation and breast cancer in women aged 66 years and older.
Hydroxychloroquine Does Not Increase Risk for Arrhythmia in Patients With SLE and RA
Researchers evaluated the link between hydroxychloroquine use and corrected QT length in patients with SLE and RA without cardiovascular disease.
- Loading...
Loading...
Next post in Arrhythmia
Loading... 
Loading...